Top Markets
#1 Helium Helium +54.86%
#2 GEKKO GEKKO +52.86%
#3 ADO Protocol ADO Protocol +38.95%
#4 StonkBroker StonkBroker +36.73%
#5 Pons Pons +36.17%
#6 TENDIES TENDIES +35.28%
#7 Prom Prom +30.65%
#8 Collector Crypt Collector Crypt +29.96%
#9 o1.exchange o1.exchange +21.00%
#10 Cysic Cysic +20.09%
Coin of the day
Helium Helium
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Jiangsu Yahong Meditech Co Ltd Jiangsu Yahong Meditech Co Ltd

Jiangsu Yahong Meditech Co Ltd

688176
शेयरों में रैंक #9583
Established in 2010 and headquartered in Shanghai, China, Jiangsu Yahong... Established in 2010 and headquartered in Shanghai, China, Jiangsu Yahong Meditech Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutic drugs. Its primary focus lies in medicines targeting genitourinary system cancers, though its pipeline extends to a variety of other diseases, serving both domestic Chinese and international markets. The company's clinical-stage pipeline features several key candidates. Notably, two compounds, APL-1202 (an anti-tumor drug) and APL-1706 (an agent drug), are both undergoing Phase III trials for the treatment of non-muscle invasive bladder cancer. Another promising candidate, APL-1501, an oral MetAP inhibitor, is currently in Phase I testing for addressing urinary system tumors and drug-resistant urinary tract infections. Furthermore, APL-1702, a photodynamic therapy product, is in Phase III for tackling cervical high-grade squamous intraepithelial lesions that arise from HPV infections. Beyond these clinical programs, Jiangsu Yahong Meditech is actively exploring targeted protein degraders in its preclinical phase. This includes ASN-1764, aimed at triple-negative breast cancer; ASN-1780, intended for metastatic castration-resistant prostate cancer; and APL-1901, designed to treat ER-positive breast cancer. The company's developmental efforts also encompass APL-1401, targeting moderately to severely active ulcerative colitis, and ASN-1733, for combating Acinetobacter baumannii infection.
शेयर मूल्य
$1.72
अंतिम समन्वयन: 2026-08-28
मार्केट कैप
$985.07M
बदलाव (1 दिन)
-0.50%
बदलाव (1 वर्ष)
6.01%
देश
CN
व्यापार Jiangsu Yahong Meditech Co Ltd (688176)

श्रेणी

Healthcare
Jiangsu Yahong Meditech Co Ltd (688176) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $1.81 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $2.70 (2022-01-01 को)
Jiangsu Yahong Meditech Co Ltd के स्टॉक मूल्य का इतिहास 2022 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 14.02%
2025 47.19%
2024 -34.35%
2023 -4.03%
2022 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 $171.67 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 $166.36 31.46%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 $37.84 25.87%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 $222.33 27.49%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $21.19 17.16%
IN